Page last updated: 2024-08-25

acamprosate and Chronic Disease

acamprosate has been researched along with Chronic Disease in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	2 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	3 (50.00)	2.80

Authors

Authors	Studies
Agabio, R; Minozzi, S; Rösner, S; Saulle, R	1
Conigrave, JH; Conigrave, KM; Lee, KSK; Purcell-Khodr, G; Vnuk, J	1
Asghari, A; Daneshi, A; Farhadi, M; Mahmoudian, S; Mirsalehi, M; Salem, MM	1
O'Brien, CP	1
Kornhuber, J; Spanagel, R	1
Ball, D; De Witte, P; Marshall, EJ; Martinez, J; Ward, RJ	1

Reviews

2 review(s) available for acamprosate and Chronic Disease

Article	Year
Baclofen for alcohol use disorder. The Cochrane database of systematic reviews, 2023, 01-13, Volume: 1 Topics: Acamprosate; Adult; Alcohol Drinking; Alcoholism; Baclofen; Chronic Disease; Female; Humans; Male; Middle Aged; Naltrexone	2023
Research advances in the understanding and treatment of addiction. The American journal on addictions, 2003, Volume: 12, Issue:s2 Topics: Acamprosate; Alcohol Deterrents; Brain; Chronic Disease; Disease Progression; Humans; Naltrexone; Narcotics; Prognosis; Recurrence; Risk Factors; Substance-Related Disorders; Taurine	2003

Trials

2 trial(s) available for acamprosate and Chronic Disease

Article	Year
Low rates of prescribing alcohol relapse prevention medicines in Australian Aboriginal Community Controlled Health Services. Drug and alcohol review, 2023, Volume: 42, Issue:7 Topics: Acamprosate; Adult; Alcoholism; Australia; Australian Aboriginal and Torres Strait Islander Peoples; Chronic Disease; Disulfiram; Health Services, Indigenous; Humans; Male; Middle Aged; Naltrexone; Secondary Prevention	2023
Impact of Acamprosate on Chronic Tinnitus: A Randomized-Controlled Trial. The Annals of otology, rhinology, and laryngology, 2020, Volume: 129, Issue:11 Topics: Acamprosate; Administration, Oral; Adolescent; Adult; Alcohol Deterrents; Audiometry, Pure-Tone; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Otoacoustic Emissions, Spontaneous; Retrospective Studies; Tinnitus; Young Adult	2020

Article

Year

Low rates of prescribing alcohol relapse prevention medicines in Australian Aboriginal Community Controlled Health Services.

Drug and alcohol review, 2023, Volume: 42, Issue:7

Topics: Acamprosate; Adult; Alcoholism; Australia; Australian Aboriginal and Torres Strait Islander Peoples; Chronic Disease; Disulfiram; Health Services, Indigenous; Humans; Male; Middle Aged; Naltrexone; Secondary Prevention

2023

Impact of Acamprosate on Chronic Tinnitus: A Randomized-Controlled Trial.

The Annals of otology, rhinology, and laryngology, 2020, Volume: 129, Issue:11

Topics: Acamprosate; Administration, Oral; Adolescent; Adult; Alcohol Deterrents; Audiometry, Pure-Tone; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Otoacoustic Emissions, Spontaneous; Retrospective Studies; Tinnitus; Young Adult

2020

Other Studies

2 other study(ies) available for acamprosate and Chronic Disease

Article	Year
[Glutamate receptor agonists and alcohol dependence. Preclinical findings]. Der Nervenarzt, 1999, Volume: 70, Issue:5 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Chronic Disease; Disease Models, Animal; Humans; Memantine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Taurine	1999
Investigation of the therapeutic efficacy of a taurine analogue during the initial stages of ethanol detoxification: preliminary studies in chronic alcohol abusers. Advances in experimental medicine and biology, 2000, Volume: 483 Topics: Acamprosate; Alcoholism; Amino Acids; Chlordiazepoxide; Chronic Disease; Ethanol; GABA Modulators; Glutamic Acid; Humans; Molecular Structure; Taurine	2000